Skip Navigation

Receive this page by email each issue: [Sign up for eTOCs]

Contents: Volume 11, Number 2, February 2000   [Index by Author] 
Other Issues: Previous Next  

Down News
Down Book reviews
Down Editorial
Down Review
Down Original articles
Down Clinical cases
Down Short reports
Down Letters to the editor


[Search ALL Issues]

Front Matter (PDF) | Back Matter (PDF)

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.

News Back

New drugs meeting in Washington: Too demanding for clinicians?
Ann Oncol 2000 11: 123. [PDF] [Request Permissions]  

Agreement over paclitaxel reinforces BMS monopoly
Ann Oncol 2000 11: 124. [PDF] [Request Permissions]  

US relaxes pressure on developing countries regarding medications
Ann Oncol 2000 11: 124. [PDF] [Request Permissions]  

WTO agreement could have threatened European health structures
Ann Oncol 2000 11: 124-125. [PDF] [Request Permissions]  

Progress in euthanasia in Switzerland and Belgium
Ann Oncol 2000 11: 125. [PDF] [Request Permissions]  

Amid growing inequalities, an invitation to act
Ann Oncol 2000 11: 125-126. [PDF] [Request Permissions]  

Medical errors kill more than does breast cancer
Ann Oncol 2000 11: 126. [PDF] [Request Permissions]  

Perhaps not everyone knows that...
Ann Oncol 2000 11: 126-129. [PDF] [Request Permissions]  

Book reviews Back

A. Timothy
Book review
Ann Oncol 2000 11: 130. [PDF] [Request Permissions]  

G. Zanetta
Book review
Ann Oncol 2000 11: 238. [PDF] [Request Permissions]  

V. Spataro
Book review
Ann Oncol 2000 11: 242. [PDF] [Request Permissions]  

Editorial Back

J. Verweij
The prognosis of prognostic factors in phase I clinical trials
Ann Oncol 2000 11: 131-132. [PDF] [Request Permissions]  

Review Back

K. Fizazi and L. Zelek
Is ‘one cycle every three or four weeks’ obsolete? A critical review of dose-dense chemotherapy in solid neoplasms
Ann Oncol 2000 11: 133-149. [Abstract] [PDF] [Request Permissions]  

Original articles Back

T. Bachelot, I. Ray-Coquard, G. Catimel, C. Ardiet, J. P. Guastalla, A. Dumortier, F. Chauvin, J. P. Droz, T. Philip, and M. Clavel
Multivariable analysis of prognostic factors for toxicity and survival for patients enrolled in phase I clinical trials
Ann Oncol 2000 11: 151-156. [Abstract] [PDF] [Request Permissions]  

C. Levy-Piedbois, I. Durand-Zaleski, H. Juhel, C. Schmitt, A. Bellanger, and P. Piedbois
Cost-effectiveness of second-line treatment with irinotecan or infusional 5-fluorouracil in metastatic colorectal cancer
Ann Oncol 2000 11: 157-161. [Abstract] [PDF] [Request Permissions]  

J. Janinis, P. Papakostas, G. Samelis, D. Skarlos, P. Papagianopoulos, and G. Fountzilas
Second-line chemotherapy with weekly oxaliplatin and high-dose 5-fluorouracil with folinic acid in metastatic colorectal carcinoma: A Hellenic Cooperative Oncology Group (HeCOG) phase II feasibility study
Ann Oncol 2000 11: 163-167. [Abstract] [PDF] [Request Permissions]  

A. Di Leo, J. Crown, J.-M. Nogaret, K. Duffy, S. Bartholomeus, S. Dolci, S. Rowan, N. O'Higgins, M. Paesmans, D. Larsimont, A. Riva, and M. J. Piccart
A feasibility study evaluating docetaxel-based sequential and combination regimens in the adjuvant therapy of node-positive breast cancer
Ann Oncol 2000 11: 169-175. [Abstract] [PDF] [Request Permissions]  

M. Orlando, M. Chacón, G. Salum, and D. R. Chacón
Low-dose continuous oral fosfestrol is highly active in 'hormone-refractory' prostate cancer
Ann Oncol 2000 11: 177-181. [Abstract] [PDF] [Request Permissions]  

R. Morant, J. Bernhard, R. Maibach, M. Borner, M. F. Fey, B. Thürlimann, E. Jacky, F. Trinkler, J. Bauer, G. Zulian, S. Hanselmann, C. Hürny, F. Hering, and for the Swiss Group for Clinical Cancer Research (SAKK)
Response and palliation in a phase II trial of gemcitabine in hormone-refractory metastatic prostatic carcinoma
Ann Oncol 2000 11: 183-188. [Abstract] [PDF] [Request Permissions]  

C. Rizzari, M. Zucchetti, V. Conter, L. Diomede, A. Bruno, L. Gavazzi, M. Paganini, P. Sparano, L. Lo Nigro, M. Aricò, M. Milani, and M. D'lncalci
L-asparagine depletion and L-asparaginase activity in children with acute lymphoblastic leukemia receiving i.m. or i.v. Erwinia C. or E. coli L-asparaginase as first exposure
Ann Oncol 2000 11: 189-193. [Abstract] [PDF] [Request Permissions]  

M. Hentrich, J. Rockstroh, R. Sandner, N. Brack, and R. Hartenstein
Acute myelogenous leukaemia and myelomonocytic blast crisis following polycytemia vera in HIV positive patients: Report of cases and review of the literature
Ann Oncol 2000 11: 195-200. [Abstract] [PDF] [Request Permissions]  

S.C. White, H. Anderson, G.C. Jayson, L. Ashcroft, M. Ranson, and N. Thatcher
Randomised phase II study of cisplatin-etoposide versus infusional carboplatin in advanced non-small-cell lung cancer and mesothelioma
Ann Oncol 2000 11: 201-206. [Abstract] [PDF] [Request Permissions]  

C. Sessa, J. Wanders, M. Roelvink, P. Dombernowsky, D. Nielsen, R. Morant, P. Drings, P. Wissel, and A.-R. Hanauske
Second-line treatment of small-cell lung cancer with the camptothecin-derivative GI147211: A study of the EORTC Early Clinical Studies Group (ECSG)
Ann Oncol 2000 11: 207-210. [Abstract] [PDF] [Request Permissions]  

F. A. Greco, J. B. Erland, L. H. Morrissey, H. A. Burris, III, R. C. Hermann, R. Steis, D. Thompson, J. Gray, and J. D. Hainsworth
Carcinoma of unknown primary site: Phase II trials with docetaxel plus cisplatin or carboplatin
Ann Oncol 2000 11: 211-215. [Abstract] [PDF] [Request Permissions]  

Clinical cases Back

D. Re, A. Schwenk, P. Hegener, S. Bamborschke, V. Diehl, and H. Tesch
Guillain-Barré syndrome in a patient with non-Hodgkin's lymphoma
Ann Oncol 2000 11: 217-220. [Abstract] [PDF] [Request Permissions]  

B. Rijnders and M. Decramer
Reversibility of paraneoplastic bilateral diaphragmatic paralysis after nephrectomy for renal cell carcinoma
Ann Oncol 2000 11: 221-225. [Abstract] [PDF] [Request Permissions]  

Short reports Back

L. M. Krug, V. A. Miller, G. P. Kalemkerian, M. J. Kraut, K. K. Ng, R. T. Heelan, B. A. Pizzo, W. Perez, N. McClean, and M. G. Kris
Phase II study of dolastatin-10 in patients with advanced non-small-cell lung cancer
Ann Oncol 2000 11: 227-228. [PDF] [Request Permissions]  

J. E. Kurtz, G. Deplanque, C. Borel, C. Mathelin, G. Prévost, G. Poulin, J. C. Barats, J. P. Bergerat, I. Chapelle-Marcillac, M. Bardonnet, and P. Dufour
Dose-finding study of oral idarubicin and cyclophosphamide in first-line treatment of elderly patients with metastatic breast cancer
Ann Oncol 2000 11: 229-230. [PDF] [Request Permissions]  

C. Tondini, M. Balzarotti, I. Rampinelli, P. Valagussa, M. Luoni, A. De Paoli, A. Santoro, and G. Bonadonna
Fludarabine and cladribine in relapsed/refractory low-grade non-Hodgkin's lymphoma: A phase II randomized study
Ann Oncol 2000 11: 231-233. [Abstract] [PDF] [Request Permissions]  

J.D. Chester, J.T. Dent, G. Wilson, E. Ride, and M.T. Seymour
Protracted infusional 5-fluorouracil (5-FU) with bolus mitomycin in 5-FU-resistant colorectal cancer
Ann Oncol 2000 11: 235-237. [Abstract] [PDF] [Request Permissions]  

S.J. Clarke, J. Zalcberg, I. Olver, P.L.R. Mitchell, D. Rischin, D. Dalley, M. Green, and Y. Egan Davidson
Open label, multi-centre phase II study of raltitrexed (‘Tomudex’) in patients with inoperable squamous-cell carcinoma of head and neck
Ann Oncol 2000 11: 239-241. [Abstract] [PDF] [Request Permissions]  

Letters to the editor Back

F. Bozzetti and P. Bignami
Recommendation for surgical treatment of colorectal liver metastascs
Ann Oncol 2000 11: 243. [PDF] [Request Permissions]  

S. Giacchetti and F. Lévi
This letter was referred to the authors, who respond as follows:: A new strategy in unresectable metastatic colorectal cancers
Ann Oncol 2000 11: 243-244. [PDF] [Request Permissions]  

T. Stroffolini, A. Andriani, and C. Di Giacomo
Sequential development of liver cirrhosis, hepatocellular carcinoma, essential mixed cryoglobulinemia, and non-Hodgkin's lymphoma in a hepatitis C-positive subject
Ann Oncol 2000 11: 244. [PDF] [Request Permissions]  

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.